Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
66.6M
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
47.3M
-
Shares change
-
+6.25M
-
Total reported value, excl. options
-
$1.8B
-
Value change
-
+$233M
-
Put/Call ratio
-
0.68
-
Number of buys
-
111
-
Number of sells
-
-83
-
Price
-
$37.97
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2018
245 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q4 2018.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.3M shares
of 66.6M outstanding shares and own 71.07% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (5.66M shares), BlackRock Inc. (4.2M shares), FRED ALGER MANAGEMENT INC (3.18M shares), LORD, ABBETT & CO. LLC (1.81M shares), FEDERATED INVESTORS INC /PA/ (1.71M shares), TimesSquare Capital Management, LLC (1.64M shares), RENAISSANCE TECHNOLOGIES LLC (1.41M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.31M shares), STATE STREET CORP (1.28M shares), and Point72 Asset Management, L.P. (1.21M shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.